肥胖与意义未明单克隆丙种球蛋白血症风险及向多发性骨髓瘤进展:一项基于人群的研究
基于人群的Age, Gene/Environment Susceptibility-Reykjavik研究(N=5764)显示,11项肥胖指标与MGUS或LC-MGUS均无关联(比值比0.81至1.15);但中年高体重指数增加MGUS向多发性骨髓瘤及其他淋巴增殖性疾病进展的风险(风险比2.66,95%CI 1.17-6.05)。
要点
- 11项肥胖指标与MGUS或LC-MGUS均无关联,比值比0.81至1.15。
- 中年高体重指数增加MGUS向多发性骨髓瘤及其他淋巴增殖性疾病进展风险,风险比2.66(95%CI 1.17-6.05)。
- 肥胖可能参与MGUS向多发性骨髓瘤的转化过程。
核心结论
- 肥胖与MGUS无关联,但超重/肥胖是MGUS向多发性骨髓瘤及其他淋巴增殖性疾病进展的危险因素,提示肥胖在MGUS向多发性骨髓瘤转化中起作用。
研究设计与样本
- 基于人群的Age, Gene/Environment Susceptibility-Reykjavik研究(N=5764),对所有受试者进行血清蛋白电泳和血清游离轻链检测以识别MGUS和LC-MGUS病例,分析纳入11项当前和既往肥胖指标,采用逻辑回归和Cox比例风险回归分析关联。
主要发现
- 共识别300例(5.2%)MGUS和275例(4.8%)LC-MGUS病例。
- 中位随访8年期间,18例进展为多发性骨髓瘤,11例进展为其他淋巴增殖性疾病。
- 11项肥胖指标与MGUS或LC-MGUS均无关联,两种疾病中所有11个变量的比值比均为0.81至1.15。
- 中年高体重指数增加向多发性骨髓瘤及其他淋巴增殖性疾病进展的风险,风险比2.66(95%置信区间1.17-6.05)。
关键数值与推荐
- 11项肥胖指标与MGUS或LC-MGUS的比值比均为0.81至1.15。
- 中年高体重指数与向多发性骨髓瘤及其他淋巴增殖性疾病进展的风险比为2.66(95%置信区间1.17-6.05)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
All multiple myeloma (MM) cases are preceded by the premalignant state monoclonal gammopathy of undetermined significance (MGUS). Results from previous studies show a positive association between obesity and MM; however, the association between obesity and MGUS is controversial. The aims were to determine (1) if obesity is associated with an increased risk of MGUS and light-chain MGUS (LC-MGUS) and (2) whether obesity is associated with a higher risk of progression to MM and other lymphoproliferative (LP) diseases. Data from the population-based Age, Gene/Environment Susceptibility-Reykjavik Study (N = 5764) were used. We performed serum protein electrophoresis and serum free light-chain assay on all subjects to identify MGUS and LC-MGUS cases. We included 11 different measures on current and previous obesity in our analysis. Logistic regression and Cox proportional-hazard regression were used to analyze the associations. A total of 300 (5.2%) MGUS and 275 (4.8%) LC-MGUS cases were identified. During a median follow-up of 8 years, 18 had progressed to MM and 11 to other LP diseases. We found no association between the 11 obesity markers and MGUS or LC-MGUS (odds ratios 0.81 to 1.15 for all 11 variables in both conditions). Interestingly, we found that high midlife body mass index increased risk of progression to MM and other LP diseases (hazard ratio, 2.66; 95% confidence interval, 1.17-6.05). To conclude, obesity was not associated with MGUS. However, we found overweight/obesity to be a risk factor for progression from MGUS to MM and other LP diseases, suggesting that obesity plays a role in the transformation of MGUS to MM.
引用
- Thordardottir M, Lindqvist EK, Lund SH, et al. Obesity and risk of monoclonal gammopathy of undetermined significance and progression to multiple myeloma: a population-based study. Blood Adv. 2017. PMID: 29296866. doi:10.1182/bloodadvances.2017007609
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。